Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA

Citations Over TimeTop 10% of 2014 papers

Abstract

Tuberculosis (TB) is one of the world's oldest and deadliest diseases, killing a person every 20 s. InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis, is the target of the frontline antitubercular drug isoniazid (INH). Compounds that directly target InhA and do not require activation by mycobacterial catalase peroxidase KatG are promising candidates for treating infections caused by INH resistant strains. The application of the encoded library technology (ELT) to the discovery of direct InhA inhibitors yielded compound 7 endowed with good enzymatic potency but with low antitubercular potency. This work reports the hit identification, the selected strategy for potency optimization, the structure-activity relationships of a hundred analogues synthesized, and the results of the in vivo efficacy studies performed with the lead compound 65.

Related Papers

• → Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations(2018)124 cited
• → ISONIAZID - MONORESISTANT TUBERCULOSIS IN BULGARIA(2020)3 cited
• → Detection of Genetic mutations in inhA and katG for Isoniazid and its Association with Rifampicin Resistance in Tuberculosis Confirmed by Line Probe Assay-its Rationality or Isoniazid Prophylaxis Empirical or DST Guided(2019)1 cited
• → Study of mutations associated with isoniazid resistance in clinical Mycobacterium tuberculosis strains from Tehran and Isfahan province tuberculosis centers by PCR and RFLP(1383–4)(2008)
• In vitro minimum inhibitory concentration of Mycobacterium tuberculosis isoniazid-resistant gene mutants(2012)